Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite
- 1 February 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (3) , 459-461
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- ST7612AA1, a Thioacetate-ω(γ-lactam carboxamide) Derivative Selected from a Novel Generation of Oral HDAC InhibitorsJournal of Medicinal Chemistry, 2014
- The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitorsBioorganic & Medicinal Chemistry Letters, 2014
- Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stagesEuropean Journal of Medicinal Chemistry, 2014
- Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitorsBioorganic & Medicinal Chemistry Letters, 2014
- Histone Deacetylase Inhibitors In The Treatment Of Cancer: Overview And PerspectivesFuture Medicinal Chemistry, 2012
- Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939Antimicrobial Agents and Chemotherapy, 2012
- Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID componentsBioorganic & Medicinal Chemistry Letters, 2010
- Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap groupBioorganic & Medicinal Chemistry, 2010
- Targeting Histone Deacetylase Inhibitors for Anti-Malarial TherapyCurrent Topics in Medicinal Chemistry, 2009
- Potent Antimalarial Activity of Histone Deacetylase Inhibitor AnaloguesAntimicrobial Agents and Chemotherapy, 2008